Here Are the 3 Most Important Numbers in Moderna's Earnings Report

Here Are the 3 Most Important Numbers in Moderna's Earnings Report
·4 min read

Moderna's (NASDAQ: MRNA) transformation from a clinical-stage biotech company to a commercial-stage one has been rapid -- and impressive. Only a year ago, Moderna didn't even have products on the market. Moderna invested four times more in R&D in the first quarter than it did in the same period a year ago.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting